Roivant Sciences Ltd ROIV
$29.93
▲ +1.04% 24H
About
Roivant Sciences Ltd. is an American multinational healthcare company that develops transformative medicines and technologies by creating agile, focused subsidiaries called Vants. These Vants target specific therapeutic areas, including autoimmune diseases through Immunovant, severe autoimmune conditions via Priovant, …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited Kingdom
Employees750
TickerROIV
Statistics
Market Cap$21.56B
Revenue (TTM)$8.3M
Net Income-$299.8M
Net Margin-3629.2%
EPS$-0.54
P/E1.95
P/S2529.64
P/B4.83
EV/EBITDA-13.69
ROE-7.6%
Dividend Yield—
Price$29.93
Data: Twelve Data · Revenue = mcap / P/S